GET THE APP
Vitiligo Innovations | Open Access Journals
Journal of Dermatology and Dermatologic Diseases

Journal of Dermatology and Dermatologic Diseases

ISSN: 2684-4281

Open Access
Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Submit Manuscript arrow_forward arrow_forward ..

Vitiligo Innovations

Vitiligo is an acquired condition, often familial, characterized by progressive loss of melanocytes from the epidermis and the epidermal appendages, resulting in skin areas without pigmentation. Vitiligo is a relatively common skin disease, with an estimated prevalence of 0.5-1% in most populations. It affects people of all backgrounds and both genders. Half of vitiligo patients have an onset before the age of 20 years. Although the precise etiology of the disease is still unclear, recent data support that vitiligo is a T-cell mediated autoimmune disease, maybe triggered by oxidative stress The treatment of vitiligo is aimed at halting disease progression and inducing repigmentation, achieving an acceptable cosmetic result. To date, many medical and surgical treatments Surgical therapies should be reserved for stable recalcitrant lesions, which did not achieve cosmetically pleasing results with medical treatments. Moreover a wide range of medical treatments are now available, such as steroids, ultraviolet radiations, lasers, calcineurin inhibitors, topical immune-modulators, 5-FU, prostaglandin analogs, topical vitamin D analogues and many others. Among these topical steroids and phototherapy are the more appreciated medical therapeutic options.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Medical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 4

Journal of Dermatology and Dermatologic Diseases received 4 citations as per Google Scholar report

Citation image
Journal of Dermatology and Dermatologic Diseases peer review process verified at publons
Publon image

Indexed In

Related Links

PMC/PubMed Indexed Articles
Cutaneous Expression of A Disintegrin-like and Metalloprotease domain containing Thrombospondin Type 1 motif-like 5 (ADAMTSL5) in Psoriasis goes beyond Melanocytes
 

Open Access Journals

arrow_upward arrow_upward